Literature DB >> 17721016

Early and mid-term impacts of cardiopulmonary bypass on coronary artery bypass grafting in patients with poor left ventricular dysfunction: a propensity score analysis.

Young-Nam Youn1, Byung-Chul Chang, You-Sun Hong, Young-Lan Kwak, Kyung-Jong Yoo.   

Abstract

BACKGROUND: Cardiopulmonary bypass may exacerbate myocardial damage in compromised left ventricles. Early and mid-term outcomes of off-pump coronary artery bypass grafting (OPCAB) vs on-pump coronary artery bypass grafting (On-pump CABG) were compared in patients with poor left ventricular dysfunction, using an analysis of a propensity score matching. METHODS AND
RESULTS: Between December 2000 and November 2005, 1,473 patients underwent isolated coronary artery bypass grafting in our institute and 153 patients who had a left ventricular ejection fraction (LVEF) lower than 35% were enrolled. The OPCAB group contained 100 patients and the On-pump CABG group contained 53 patients. Preoperative risk factors were compared and 50 patients in each group were matched. The mean follow-up time was 35.5+/-17.3 months. Three deaths (3.0%) occurred in the matched cohort, with no significant difference between 2 groups. The operation time, ventilation time, intensive care unit admission time and occurrence of respiratory failure were significantly lower in the OPCAB group. The mean LVEF of the 2 groups improved significantly. The overall 6-year actuarial survival rates of the OPCAB and On-pump CABG group were 88.2% and 72.4% (p=0.2), respectively, and there were no significant differences in 6-year rates of freedom from major adverse cardiac and cerebrovascular events (p=0.97).
CONCLUSIONS: Coronary artery bypass grafting in patients with poor left ventricular dysfunction improved myocardial function. Postoperative respiratory failure was significantly related to the cardiopulmonary bypass for surgical myocardial revascularization. Off-pump and On-pump surgical revascularization resulted in equivalent mid-term outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17721016     DOI: 10.1253/circj.71.1387

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

Review 1.  Does off-pump coronary artery bypass surgery have a beneficial effect on mortality in patients with left ventricular dysfunction?

Authors:  Omar A Jarral; Srdjan Saso; Thanos Athanasiou
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-14

Review 2.  Current state of surgical myocardial revascularization.

Authors:  Frank W Sellke; Louis M Chu; William E Cohn
Journal:  Circ J       Date:  2010-05-08       Impact factor: 2.993

3.  Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies.

Authors:  Vijayalakshmi Kunadian; Azfar Zaman; Weiliang Qiu
Journal:  Eur J Heart Fail       Date:  2011-04-08       Impact factor: 15.534

4.  Myocardial revascularization using on-pump beating heart among patients with left ventricular dysfunction.

Authors:  Ahmad K Darwazah; Vivian Bader; Ismail Isleem; Khalil Helwa
Journal:  J Cardiothorac Surg       Date:  2010-11-10       Impact factor: 1.637

5.  Relationship between N-terminal pro-B-type natriuretic peptide and renal function: the effects on predicting early outcome after off-pump coronary artery bypass surgery.

Authors:  Youn Yi Jo; Young Lan Kwak; Jonghoon Lee; Yong Seon Choi
Journal:  Korean J Anesthesiol       Date:  2011-07-21

6.  Off-pump coronary artery bypass surgery in selected patients is superior to the conventional approach for patients with severely depressed left ventricular function.

Authors:  Guido Marco Caputti; José Honório Palma; Diego Felipe Gaia; Enio Buffolo
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Short-term outcomes of on- vs off-pump coronary artery bypass grafting in patients with left ventricular dysfunction: a systematic review and meta-analysis.

Authors:  Zhiyuan Guan; Xiaoqing Guan; Kaiyun Gu; Xuanqi Lin; Jin Lin; Wenjun Zhou; Ming Xu; Fen Wan; Zhe Zhang; Chunli Song
Journal:  J Cardiothorac Surg       Date:  2020-05-11       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.